Status:
COMPLETED
Blood Glycan Biomarkers in Women With Stage IV Breast Cancer
Lead Sponsor:
University of California, Davis
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur and identify biomarkers related to cancer. PURPOSE: This research...
Detailed Description
OBJECTIVES: * To profile serum glycan biomarkers in women with metastatic stage IV breast cancer, healthy controls, and patients with noncancer medical illness. * To determine whether serial serum gl...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Patient or participant at the Women's Health Clinic, the Internal Medicine Clinic, or at the UC Davis Cancer Center, meeting 1 of the following criteria:
- Diagnosis of stage IV metastatic breast cancer, receiving active treatment with chemotherapy, endocrine therapy, or targeted therapy
- Patients/participants without cancer
- Healthy control being seen for annual exams, meeting the following criteria:
- No chronic disease
- Not on regular prescribed medications
- Patient without cancer being seen in the Internal Medicine Clinic
- Hormone receptor status not specified
- PATIENT CHARACTERISTICS:
- Menopausal status not specified
- Not pregnant or breast feeding
- No other active cancer
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 12 2016
Estimated Enrollment :
163 Patients enrolled
Trial Details
Trial ID
NCT00897962
Start Date
September 1 2006
End Date
January 12 2016
Last Update
December 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Davis Cancer Center
Sacramento, California, United States, 95817